Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model.
Dougherty, Urszula
Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2008 - 2253-62 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1078-0432
10.1158/1078-0432.CCR-07-4926 doi
Animals
Azoxymethane--toxicity
CCAAT-Enhancer-Binding Protein-beta--physiology
Colonic Neoplasms--etiology
Cyclin D
Cyclins--analysis
Disease Progression
ErbB Receptors--antagonists & inhibitors
Gefitinib
Male
Precancerous Conditions--etiology
Quinazolines--therapeutic use
Rats
Rats, Inbred F344
STAT3 Transcription Factor--physiology
Transcription Factor AP-1--physiology
Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Apr 2008 - 2253-62 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1078-0432
10.1158/1078-0432.CCR-07-4926 doi
Animals
Azoxymethane--toxicity
CCAAT-Enhancer-Binding Protein-beta--physiology
Colonic Neoplasms--etiology
Cyclin D
Cyclins--analysis
Disease Progression
ErbB Receptors--antagonists & inhibitors
Gefitinib
Male
Precancerous Conditions--etiology
Quinazolines--therapeutic use
Rats
Rats, Inbred F344
STAT3 Transcription Factor--physiology
Transcription Factor AP-1--physiology